The Cost of Gastro-Oesophageal Reflux Disease, Dyspepsia and Peptic Ulcer Disease in Sweden

Authors: Agréus L.¹; Borgquist L.²

Source: PharmacoEconomics, Volume 20, Number 5, 2002 , pp. 347-355(9)

Buy & download fulltext article:

Price: $62.95 plus tax (Refund Policy)

Abstract:

Background and objective: Dyspepsia, peptic ulcer disease (PUD) and gastro-oesophageal reflux disease (GORD) involve a substantial cost to Swedish society. There is a lack of up-to-date nationwide cost estimates after 1985. This study was conducted to present a comprehensive and updated cost analysis and study the change over time of the national cost of these disorders.

Design and setting: Primarily, data from National Swedish databases and secondly, data from databases from the County of Uppsala for 1997 were used for the calculations and estimations.

Perspective: Swedish societal perspective.

Results: The total cost to Swedish society of dyspepsia, PUD and GORD in 1997 was $US424 million, or $US63 per adult. Direct costs totalled $US258 million (61%) while indirect costs totalled $US166 million (39%). The highest proportions of costs were due to drugs and sick leave, these being 37 and 34%, respectively.

Conclusions: The cost of dyspepsia and GORD is substantial for patients, health providers and society. Since 1985, drug costs have increased substantially while the cost of sick leave has decreased.

Keywords: Cost of illness; Dyspepsia, treatment; Gastro oesophageal reflux, treatment; Peptic ulcer, treatment; Pharmacoeconomics

Language: English

Document Type: Original article

Affiliations: 1: Family Medicine Stockholm, Karolinska Institute, Stockholm, Sweden 2: Institute of Health, Society and Primary Care, Faculty of Health Sciences, Linköping University, Linköping , Sweden *

Publication date: 2002-01-01